Taken together, these results demonstrated that Vγ2 x PD-L1 could redirect Vγ2Vδ2 T cells to kill PD-L1+ tumor cell lines with IFNγ secretion, but to leave PD-L1 negative tumor cells and healthy cells un-attacked. This evidence concerns the gene IFNG and neoplasm.